(PRESS RELEASE) PARIS, 28-Aug-2020 — /EuropaWire/ — French multinational pharmaceutical company Sanofi announces its intention to commence a tender offer (the “Offer”) to acquire all of the outstanding shares of common stock of Principia Biopharma Inc. for $100 per share … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech
Tagged acquisition, biopharmaceutical, BofA Securities, BTK inhibitor, Centerview Partners LLC, Cooley LLP, Evercore, Gotshal & Manges LLP, Healthcare, immune thrombocytopenia, immune-mediated diseases, ITP, Kortex Acquisition Corp., MERGER, Merger Agreement, outstanding shares, Principia Biopharma Inc., rilzabrutinib, Sanofi, stock, Tailored Covalency®, tender offer, Weil
This stock exchange release may not be published or distributed, in whole or in part, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Singapore or the United States or any other country where … Read the full press release
Posted in Business, Financial, Industrial, Investment, Sweden
Tagged Ahlstrom-Munksjö, Financial, investors, shares, stock, Sweden, trade, trading
Disclosure of Transactions in Own Shares – Period from December 03, 2018 to December 07, 2018 AMSTERDAM, 11-Dec-2018 — /EuropaWire/ — STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full … Read the full press release
Posted in Business, Electronics & Machinery, Investment, Netherlands, Technology
Tagged Financial, investment, semiconductors, SHARE, share buyback, shares, STMicroelectronics N.V., stock
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
